Bayer sells animal health division for $7.6 billion, denies deal brought on by glyphosate-most cancers proceedings
Agriculture and pharmaceutical huge Bayer [August 20] agreed [to] a $7.6 billion deal to sell its animal health industry to U.S.-basically based animal health firm Elanco …. The take care of Elanco strategy Bayer will now no longer assemble products that stop and take care of ailments in cattle and pets.
Bayer finds itself in a strong political scenario after its $63 billion acquisition of glyphosate-maker Monsanto closing 365 days. Having taken on the liability for the controversial weedkiller, Bayer has been facing a wave of claims from plaintiffs asserting glyphosate precipitated their most cancers …. Bayer …. denied any hyperlink between the glyphosate proceedings and the animal health sell-off.
Learn fleshy, customary article: Bayer sells animal health industry (At the help of paywall)
The GLP aggregated and excerpted this text to reproduction the range of files, belief, and analysis. Click on the hyperlink above to be taught the fleshy, customary article.